Cardioversion of Atrial Fibrillation Accompanied by Chronic Heart Faliure

Cardioversion of Atrial Fibrillation Accompanied by Chronic Heart Faliure With or Without HTEA

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02292030

Enrollment

Registered

2014-11-17

Start date

2014-11-30

Completion date

2015-10-31

Last updated

2014-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Heart Failure

Brief summary

The purpose of this study is to explore the efficacy of low energy cardioversion on atrial fibrillation accompanied with chronic heart failure treated with HTEA or usual medicine.

Detailed description

The purpose of this study is to explore the efficacy of low energy (30J) cardioversion on atrial fibrillation accompanied with chronic heart failure treated with HTEA or usual medicine.

Interventions

DRUGHTEA

usually high thoracic epidural anesthesia

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

20 Years to 70 Years

Healthy volunteers

Inclusion criteria

* congestive heart failure accompanied by atrial fibrillation.

Exclusion criteria

* Valvular heart diseases.

Design outcomes

Primary

Measure	Time frame
recurrence of atrial fibrillation	1 year

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026